Clinical Trial Update: Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating transplantation of autologous stem cell–derived dopaminergic neurons to treat Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Autologous stem cell-derived dopaminergic neuron transplantation product (autologous stem cell-derived dopaminergic neurons)

Snippet

Sponsor: Jeffrey S. Schweitzer, MD, PhD | Conditions: Parkinson Disease | Phase 1 | Status: RECRUITING